---
figid: PMC7793796__fonc-10-592733-g005
figtitle: CAM-DR in leukemia
organisms:
- Homo sapiens
- Mus musculus
- Sus scrofa
organisms_ner:
- Sus scrofa
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC7793796
filename: fonc-10-592733-g005.jpg
figlink: pmc/articles/PMC7793796/figure/f5/
number: F5
caption: Overview of CAM-DR in leukemia. Cadherin, selectin, and integrin contribute
  to drug-resistance and metastasis upon engagement with their ligands in the BM.
  Homotropic engagment of cadherins can protect leukemia cells from chemotherapy (reference
  , ) by modulating Wnt signaling and promote self-renewal of LSCs (reference , ,
  ). Leukemia cells can also bind to E-selectin expressed on endothelial cells through
  expressed selectin ligands on their surface (ref , ). Interruption of E-selectin
  mediated interaction between leukemia and endothelial cells is actively being investigated
  in many clinical trials (ref ). Integrin binding to BM stromal cells, ECM or counter
  receptors activates pro-survival signaling pathways such as PI3K/AKT and Ras/ERK
  pathway (ref , , , ).
papertitle: Cadherins, Selectins, and Integrins in CAM-DR in Leukemia.
reftext: Hye Na Kim, et al. Front Oncol. 2020;10:592733.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9105866
figid_alias: PMC7793796__F5
figtype: Figure
redirect_from: /figures/PMC7793796__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7793796__fonc-10-592733-g005.html
  '@type': Dataset
  description: Overview of CAM-DR in leukemia. Cadherin, selectin, and integrin contribute
    to drug-resistance and metastasis upon engagement with their ligands in the BM.
    Homotropic engagment of cadherins can protect leukemia cells from chemotherapy
    (reference , ) by modulating Wnt signaling and promote self-renewal of LSCs (reference
    , , ). Leukemia cells can also bind to E-selectin expressed on endothelial cells
    through expressed selectin ligands on their surface (ref , ). Interruption of
    E-selectin mediated interaction between leukemia and endothelial cells is actively
    being investigated in many clinical trials (ref ). Integrin binding to BM stromal
    cells, ECM or counter receptors activates pro-survival signaling pathways such
    as PI3K/AKT and Ras/ERK pathway (ref , , , ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - GSK3B
  - AKT1
  - SPN
  - CD44
  - LYMPH
  - VCAM1
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ARHGEF1
  - AKT2
  - AKT3
  - SELE
  - SELL
  - SELP
  - SELPLG
  - BCL2L11
  - Ctnnb1
  - Arhgef1
  - Gsk3b
  - Akt1
  - Spn
  - Cd44
  - Selplg
  - Sytl1
  - Bcl2l11
  - Vcam1
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - arm
  - l(1)sc
  - sgg
  - Axn
  - gskt
  - Akt
  - scb
  - leukemia
---
